| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |